{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:33:16Z","timestamp":1768321996769,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.bone.2011.01.015","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T04:37:22Z","timestamp":1296103042000},"page":"1133-1139","source":"Crossref","is-referenced-by-count":21,"title":["Prospective one-year bone loss in treatment-na\u00efve HIV+ men and women on single or multiple drug HIV therapies"],"prefix":"10.1016","volume":"48","author":[{"given":"K.","family":"Briot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kolta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Flandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bou\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ngo Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Cohen-Codar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Delfraissy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2011.01.015_bb0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2011.01.015_bb0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(05)70281-6","article-title":"Abnormal fat accumulation in patients with HIV-1 infection","volume":"351","author":"Lipsky","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2011.01.015_bb0020","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","article-title":"Osteopenia in HIV-infected patients: is it the disease or is it the treatment?","volume":"15","author":"Knobel","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0030","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.86.8.3533","article-title":"Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting","volume":"86","author":"Huang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2011.01.015_bb0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002030-200402200-00014","article-title":"Reduced bone density in HIV-infected women","volume":"18","author":"Dolan","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0045","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case\u2013control population-based study","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2011.01.015_bb0050","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2011.01.015_bb0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","article-title":"Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection","volume":"21","author":"Arnsten","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0060","series-title":"Oral Abstract 128, Session 37. 17th Conference on Retroviruses and Opportunistic Infections","article-title":"Higher and increasing rates of fracture among hiv-infected persons in the HIV outpatient study compared to the general US population, 1994 to 2008","author":"Dao","year":"2010"},{"key":"10.1016\/j.bone.2011.01.015_bb0065","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00002030-200104130-00005","article-title":"Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0075","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","article-title":"Bone mass and mineral metabolism in HIV+ postmenopausal women","volume":"16","author":"Yin","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2011.01.015_bb0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bone.2005.11.001","article-title":"Potential predictive factors of osteoporosis in HIV-positive subjects","volume":"38","author":"Fausto","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2011.01.015_bb0085","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-007-0524-8","article-title":"Risk factors for decreased bone density and effects of HIV on bone in the elderly","volume":"19","author":"Jones","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2011.01.015_bb0095","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0100","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"Continuous antiretroviral therapy decreases bone mineral density","volume":"23","author":"Grund","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0105","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/jc.2007-1660","article-title":"Low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis","volume":"92","author":"Bolland","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2011.01.015_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QAD.0b013e3282f3f16d","article-title":"Lopinavir\/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients","volume":"22","author":"Delfraissy","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0115","series-title":"Poster presentation WEPEB118LB. 4th IAS conference on HIV pathogenesis, treatment and prevention","article-title":"One-year fat tissue distribution changes in antiretroviral naive HIV-infected patients treated with lopinavir\/ritonavir (LPV\/r) monotherapy versus LPV\/r with zidovudine\/lamivudine (AZT\/3TC) in the MONARK trial","author":"Delfraissy","year":"2007"},{"key":"10.1016\/j.bone.2011.01.015_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.292.2.251","article-title":"Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA panel","volume":"292","author":"Yeni","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2011.01.015_bb0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","article-title":"Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel","volume":"300","author":"Hammer","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2011.01.015_bb0130","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results","volume":"9","author":"Genant","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2011.01.015_bb0135","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","article-title":"Individual smallest detectable difference in bone mineral density measurements","volume":"14","author":"Ravaud","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2011.01.015_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1346.057","article-title":"Pathogenesis of osteopenia\/osteoporosis induced by highly active anti-retroviral therapy for AIDS","volume":"1068","author":"Pan","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bone.2011.01.015_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00126334-200403010-00007","article-title":"Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases","volume":"35","author":"Peyriere","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bone.2011.01.015_bb0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2011.01.015_bb0155","series-title":"Poster presentation 749. 17th conference on retroviruses and opportunistic infections","article-title":"Renal phosphate wasting and increased boneturnover in TDF-treated patients are not mediated by low 25(oh) vitamin d or hyperparathyroidism","author":"Wirz","year":"2010"},{"key":"10.1016\/j.bone.2011.01.015_bb0160","series-title":"Poster presentation 193. 17th conference on retroviruses and opportunistic infections","article-title":"Changes in bone mineral density: two-years follow-up of the ANRS CO3 Aquitaine cohort","author":"Cazanave","year":"2010"},{"key":"10.1016\/j.bone.2011.01.015_bb0165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jocd.2007.07.006","article-title":"Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls","volume":"10","author":"Delpierre","year":"2007","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.bone.2011.01.015_bb0170","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2006-0127","article-title":"Longitudinal analysis of bone density in human immunodeficiency virus-infected women","volume":"91","author":"Dolan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2011.01.015_bb0175","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","article-title":"Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir","volume":"15","author":"Nolan","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181893e8e","article-title":"Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study","volume":"49","author":"Jacobson","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bone.2011.01.015_bb0185","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bone.2011.01.015_bb0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","article-title":"Prospective, intensive study of metabolic changes associated with 48weeks of amprenavir-based antiretroviral therapy","volume":"35","author":"Dube","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bone.2011.01.015_bb0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0200","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/QAD.0b013e32832c4947","article-title":"First line zidovudine\/lamivudine\/lopinavir\/ritonavir leads to greater bone loss compared to nevirapine\/lopinavir\/ritonavir","volume":"23","author":"van Vonderen","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-1293.2007.00525.x","article-title":"Evolution of bone mineral density in AIDS patients on treatment with zidovudine\/lamivudine plus abacavir or lopinavir\/ritonavir","volume":"9","author":"Rivas","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.bone.2011.01.015_bb0210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2011.01.015_bb0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bone.2011.01.015_bb0220","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/JBMR.0301246","article-title":"BMD is reduced in HIV-infected men irrespective of treatment","volume":"19","author":"Amiel","year":"2004","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328211000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328211000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T02:24:27Z","timestamp":1543976667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328211000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S8756328211000196"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2011.01.015","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}